Ventus is supported by a syndicate of top-tier healthcare investors. A broad syndicate of top-tier healthcare investors have invested $290 million to date. Global private equity and venture capital investment platform. Specialized and diversified healthcare funds spanning all sectors and stages. Ventus is applying structural immunology to discover and develop therapeutics targeting innate immune pathways to address human disease.
This profile has not yet been verified by the firm. Information may be incomplete or outdated. Claim this profile to take control of your listing.
Claim this profile to complete your information, set investment criteria, and start receiving curated deal flow from sponsors on DEALITHIC.